.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Merck
McKinsey
Fish and Richardson
McKesson
Cipla
Federal Trade Commission
Teva
QuintilesIMS

Generated: December 16, 2017

DrugPatentWatch Database Preview

GEMFIBROZIL Drug Profile

« Back to Dashboard

When do Gemfibrozil patents expire, and what generic alternatives are available?

Gemfibrozil is a drug marketed by Mylan, Purepac Pharm, Apotex, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Caribe Holdings, Chartwell Molecules, Hikma Pharms, Impax Pharms, Invagen Pharms, Northstar Hlthcare, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs. and is included in eighteen NDAs.

The generic ingredient in GEMFIBROZIL is gemfibrozil. Fifty-one suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the gemfibrozil profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
MylanGEMFIBROZILgemfibrozilCAPSULE;ORAL073466-001Jan 25, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsGEMFIBROZILgemfibrozilTABLET;ORAL074442-001Apr 28, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell MoleculesGEMFIBROZILgemfibrozilTABLET;ORAL074270-001Sep 27, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdGEMFIBROZILgemfibrozilTABLET;ORAL202726-001Sep 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Northstar HlthcareGEMFIBROZILgemfibrozilTABLET;ORAL079072-001Sep 13, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma PharmsGEMFIBROZILgemfibrozilTABLET;ORAL078599-001Aug 16, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaGEMFIBROZILgemfibrozilTABLET;ORAL074256-001Oct 31, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
SandozGEMFIBROZILgemfibrozilTABLET;ORAL074615-001Sep 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac PharmGEMFIBROZILgemfibrozilCAPSULE;ORAL072929-001Jan 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
ApotexGEMFIBROZILgemfibrozilTABLET;ORAL075034-001Jul 20, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Covington
QuintilesIMS
Express Scripts
Julphar
Citi
McKesson
Federal Trade Commission
Moodys
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot